AORTIC ANEURYSM

✓ Medically ReviewedDISEASEID: MDBT0176🚨 TRIAGE: EMERGENCYICD-10: I71.9

📖

Definition

CLINICAL DEFINITION

An aortic aneurysm is a localised, pathological dilatation of the aorta, defined as a permanent increase in its diameter of at least 50% compared to the normal expected diameter for a given age, sex, and body size. It can occur in the thoracic aorta, abdominal aorta, or involve both segments.

IN PLAIN ENGLISH

An aortic aneurysm is a weakened, bulging area in the wall of the aorta, the main artery carrying blood from the heart to the rest of the body. If it grows too large, it can burst, causing life-threatening internal bleeding.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Aortic aneurysm is NOT the same as an aortic dissection, although an aneurysm can predispose to dissection. It is also distinct from normal age-related aortic ectasia or mild dilatation that does not meet the 50% threshold criteria for an aneurysm.

🔤

Word Breakdown

aort-

=aorta (from Greek 'aorte', to raise or heave)

-aneurysm

=widening, dilatation (from Greek 'aneurysma', a widening)

Literal Meaning: A widening or ballooning of the aorta

🏷️

Abbreviations

AAA=Abdominal Aortic Aneurysm — the most common subtype of aortic aneurysm

TAA=Thoracic Aortic Aneurysm — aneurysm located in the chest portion of the aorta

🔄

Synonyms & Variants

Aneurysm of Aorta›Aortic Dilatation›

🎯

Category-Specific Context

As a vascular disease, aortic aneurysms are classified anatomically into thoracic (involving the ascending aorta, arch, or descending thoracic aorta) and abdominal (infrarenal or suprarenal). They are further characterised by morphology (fusiform versus saccular) and aetiology (degenerative, genetic, inflammatory, or infectious).

🏥

Clinical Context & Usage

CLINICAL SETTINGS

Vascular Surgery ClinicEmergency DepartmentCardiology WardIntensive Care UnitGeneral Practice

USAGE & DOCUMENTATION NOTES

In clinical notes, the size of the aneurysm is always documented in centimetres or millimetres (e.g., '5.5 cm infrarenal AAA'). Growth rate is tracked over time (e.g., 'expanding at 0.5 cm/year'). Morphology is described as fusiform or saccular, and the relationship to major branches (e.g., renal arteries, coeliac trunk) is specified for surgical planning.

🔬

Primary Causes & Pathophysiology

PATHOPHYSIOLOGY

The pathophysiology of aortic aneurysm involves progressive degradation of the extracellular matrix in the aortic wall, particularly elastin and collagen, driven by an imbalance between matrix metalloproteinases (MMPs) and their tissue inhibitors. This structural weakening is compounded by chronic inflammation, oxidative stress, and apoptosis of vascular smooth muscle cells. Haemodynamic stress, particularly hypertension, exerts outward wall tension (Laplace's law), leading to progressive dilatation. As the diameter increases, wall tension rises exponentially, creating a vicious cycle of expansion that ultimately predisposes the vessel to rupture or dissection.

PRIMARY CAUSES

Atherosclerosis and Degenerative Disease

Chronic inflammation, lipid deposition, and extracellular matrix degradation weaken the aortic wall, predominantly affecting the infrarenal abdominal aorta.

Genetic Connective Tissue Disorders

Mutations in fibrillin-1 (Marfan syndrome) or type III collagen (vascular Ehlers-Danlos syndrome) cause inherent structural weakness of the aortic media, typically leading to thoracic aortic aneurysms.

Bicuspid Aortic Valve (BAV)

Associated with cystic medial necrosis and abnormal haemodynamic shear stress, predisposing to ascending thoracic aortic aneurysms.

Chronic Hypertension

Elevated intraluminal pressure increases wall stress, accelerating medial degeneration and aneurysmal dilatation.

Mycotic (Infectious) Aneurysm

Bacterial seeding of the aortic wall (e.g., Salmonella, Staphylococcus) during bacteraemia causes localised suppurative destruction and saccular aneurysm formation.

Inflammatory Aortitis

Autoimmune conditions like Takayasu arteritis or Giant Cell Arteritis cause transmural inflammation and subsequent aneurysmal or stenotic remodelling.

💊

Drug-Induced Causes

💊 Fluoroquinolones (e.g., ciprofloxacin, levofloxacin) ↗

Mechanism: Upregulate matrix metalloproteinases, leading to collagen degradation and increased risk of aortic aneurysm expansion or rupture.

→ Avoid fluoroquinolones in patients with known aortic aneurysm or high risk (e.g., Marfan syndrome) unless no alternative antibiotics are available.

🌍

Epidemiology

Prevalence:Abdominal aortic aneurysm (AAA) prevalence is approximately 4–8% in men and 0.5–1.5% in women over the age of 65 in Western populations. Thoracic aortic aneurysm (TAA) is less common, with an estimated incidence of 5–10 per 100,000 person-years.

Age Group:Degenerative AAAs predominantly affect adults over 65. Genetic TAAs (e.g., Marfan syndrome) often present in young adults or adolescents. Inflammatory and mycotic aneurysms can occur at any age depending on the underlying condition.

Sex Predilection:Male

Geographic Distribution:Higher prevalence of AAA is observed in North America, Northern Europe, and Australasia, correlating with high rates of smoking and atherosclerosis. Lower prevalence is reported in Asian and African populations, though this may partly reflect differences in screening and diagnostic imaging access.

Red Flags & Triage ★

TRIAGE LEVEL

🚨 EMERGENCY

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

Symptomatic AAA (abdominal, back, or flank pain) in an older adult with a pulsatile mass requires immediate ultrasound or CTA to rule out impending rupture or contained leak, mandating emergency vascular surgery consultation.
Sudden onset tearing chest or interscapular pain in a patient with known TAA or connective tissue disorder raises high suspicion for acute aortic dissection, requiring immediate CTA and strict blood pressure and heart rate control.

URGENT EVALUATION TRIGGERS

New onset abdominal, back, or flank pain in a patient with a known AAA
Palpable, expansile, pulsatile abdominal mass with hypotension or syncope
Rapid aneurysm expansion (> 0.5 cm in 6 months) on surveillance imaging
Aneurysm diameter reaching 5.5 cm (AAA) or 5.5 cm (TAA) on routine screening

Contraindications & Precautions

CONTRAINDICATIONS

Open surgical repair is relatively contraindicated in patients with severe
uncorrectable cardiopulmonary comorbidities or hostile abdomen (e.g.
multiple prior laparotomies
stoma)
Endovascular aneurysm repair (EVAR) is contraindicated if the patient lacks suitable vascular access or adequate proximal/distal landing zones for stent-graft seal

SPECIAL PRECAUTIONS

Strict blood pressure control is essential to reduce wall stress and slow expansion
Smoking cessation is the most critical modifiable factor to reduce the rate of aneurysm growth
Avoid heavy isometric lifting or straining
which causes acute spikes in intra-abdominal and intrathoracic pressure

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Aortic Rupture — catastrophic internal bleeding with mortality exceeding 80% outside the hospital
Aortic Dissection — intimal tear allowing blood to enter the media
potentially causing branch vessel malperfusion
Distal Embolisation — thrombus formation within the aneurysm sac can embolise to the lower extremities (blue toe syndrome)
Aortoenteric Fistula — erosion of an AAA into the duodenum
causing massive gastrointestinal bleeding
Compression of Adjacent Structures — large aneurysms may compress the ureter (hydronephrosis)
inferior vena cava
or duodenum

🔀

Confused With (LASA & DDx) ★

LEXICAL (LASA) — SIMILAR NAMES

Aortic Dissection

Often confused or co-occurring; dissection is a tear in the intimal layer creating a false lumen, whereas an aneurysm is a true dilatation of all three vessel wall layers.

Aortic Ectasia

Ectasia refers to mild, diffuse dilatation (typically < 50% increase over normal) that does not meet the strict criteria for an aneurysm.

CLINICAL DIFFERENTIAL DIAGNOSES (DDx)

Aortic Dissection

Key Distinguishing Feature: Presents with sudden, tearing chest or back pain; imaging shows an intimal flap and false lumen rather than simple dilatation.

Aortic Pseudoaneurysm

Key Distinguishing Feature: Contained rupture where the outer wall is formed by adventitia or perivascular soft tissue, usually secondary to trauma, infection, or prior surgery.

Renal Colic

Key Distinguishing Feature: Can mimic the flank pain of an expanding AAA, but ultrasound/CT shows ureteric stones and hydronephrosis rather than aortic dilatation.

Acute Myocardial Infarction

Key Distinguishing Feature: Thoracic aneurysm expansion or rupture can mimic ACS; ECG and troponins help differentiate, though both can coexist or TAA can involve coronary ostia.

💎

Clinical Pearls

💎

Laplace's Law dictates that wall tension is proportional to the product of pressure and radius; therefore, as an aneurysm dilates, wall tension increases exponentially, explaining why larger aneurysms grow faster and have a much higher risk of rupture.

💎

Routine ultrasound screening for AAA is highly cost-effective and recommended by major guidelines for men aged 65–75 with any history of smoking, as most AAAs are asymptomatic until rupture.

💎

While beta-blockers are foundational for slowing TAA growth in Marfan syndrome, their benefit in slowing the expansion of degenerative infrarenal AAA is less clear, though they remain important for overall cardiovascular risk reduction.

💎

Endovascular aneurysm repair (EVAR) has lower perioperative mortality than open repair but requires lifelong surveillance with CTA or duplex ultrasound to monitor for endoleaks, graft migration, or sac expansion.

📝

Example Usage & SOAP

CLINICAL SENTENCE

"Surveillance ultrasound revealed a 5.2 cm fusiform infrarenal abdominal aortic aneurysm, expanded from 4.8 cm six months ago, prompting urgent referral to vascular surgery for consideration of elective EVAR."

IN A SOAP NOTE

S: 72-year-old male with a history of hypertension and a 40-pack-year smoking history presents for routine AAA surveillance. Reports no abdominal, back, or flank pain. O: BP 145/85 mmHg, HR 72 bpm. Abdomen soft, non-tender, with a palpable, non-expansile pulsatile mass in the midline. Ultrasound demonstrates a 5.3 cm infrarenal AAA with no evidence of leak. A: Asymptomatic expanding infrarenal AAA, now > 5.0 cm and approaching the 5.5 cm threshold for elective repair. P: Counsel on strict smoking cessation and BP control. Refer to vascular surgery for CTA planning and discussion of elective EVAR versus open repair. Repeat ultrasound in 3 months if surgery is delayed.

DIFFERENTIAL DIAGNOSIS CONTEXT

Differential for a pulsatile abdominal mass: (1) Abdominal Aortic Aneurysm — expansile mass, confirmed by ultrasound; (2) Normal aortic pulsation in a thin patient — non-expansile, normal diameter on imaging; (3) Transmitted pulsation from a retroperitoneal mass or lymphadenopathy overlying the aorta — mass does not expand laterally with systole.

📈

Prognosis

SHORT-TERM OUTCOME

Elective endovascular or open repair carries a 30-day mortality of 1–2% for AAA and 2–5% for TAA. Ruptured AAA carries a perioperative mortality of 40–50%, with overall population mortality exceeding 80%.

LONG-TERM PROGNOSIS

Patients with repaired aneurysms require lifelong surveillance imaging due to the risk of endoleak (EVAR), graft infection, or metachronous aneurysm formation. Long-term survival is largely dictated by concomitant cardiovascular disease burden.

📚

References & Coding

ICD-10 DIAGNOSTIC CODE

I71.9

LITERATURE CITATIONS & GUIDELINES

[1]Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg. 2018;67(1):2-77.e2.

[2]Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014;35(41):2873-2926.

[3]Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with thoracic aortic disease. Circulation. 2010;121(13):e266-e369.

[4]US Preventive Services Task Force. Screening for Abdominal Aortic Aneurysm: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(23):2340-2348.

MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.